We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
31 hedge funds and large institutions have $1.87M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
25% more call options, than puts
Call options by funds: $15K | Put options by funds: $12K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
21% less funds holding
Funds holding: 39 → 31 (-8)
44% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 9
47% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 17
96% less capital invested
Capital invested by funds: $49.2M → $1.87M (-$47.3M)
Holders
31
Holders Change
-8
Holders Change %
-20.51%
% of All Funds
0.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
5
Reduced
9
Closed
17
Calls
$15K
Puts
$12K
Net Calls
+$3K
Net Calls Change
-$28K
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$478K |
| 2 |
Two Sigma Advisers
New York
|
+$326K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$194K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$170K |
| 5 |
Morgan Stanley
New York
|
+$93.7K |
